Trial Profile
Phase I trial of taurolidine after positive second look surgery for recurrent ovarian epithelial, fallopian tube and primary peritoneal cancers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jul 2015
Price :
$35
*
At a glance
- Drugs Taurolidine (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 10 Sep 2005 New trial record.